Your browser doesn't support javascript.
loading
Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives.
Zafer, Mai M; Mohamed, Gamal A; Ibrahim, Sabrin R M; Ghosh, Soumya; Bornman, Charné; Elfaky, Mahmoud A.
Afiliação
  • Zafer MM; Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Cairo, Egypt. maizafer@acu.edu.eg.
  • Mohamed GA; Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
  • Ibrahim SRM; Department of Chemistry, Preparatory Year Program, Batterjee Medical College, 21442, Jeddah, Saudi Arabia.
  • Ghosh S; Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
  • Bornman C; Natural and Medical Science Research Center, University of Nizwa, Nizwa, 616, Oman.
  • Elfaky MA; Department of Engineering Sciences, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, 9301, South Africa.
Arch Microbiol ; 206(3): 101, 2024 Feb 14.
Article em En | MEDLINE | ID: mdl-38353831
ABSTRACT
A biofilm is a collection of microorganisms organized in a matrix of extracellular polymeric material. Biofilms consist of microbial cells that attach to both surfaces and each other, whether they are living or non-living. These microbial biofilms can lead to hospital-acquired infections and are generally detrimental. They possess the ability to resist the human immune system and antibiotics. The National Institute of Health (NIH) states that biofilm formation is associated with 65% of all microbial illnesses and 80% of chronic illnesses. Additionally, non-device-related microbial biofilm infections include conditions like cystic fibrosis, otitis media, infective endocarditis, and chronic inflammatory disorders. This review aims to provide an overview of research on chronic infections caused by microbial biofilms, methods used for biofilm detection, recent approaches to combat biofilms, and future perspectives, including the development of innovative antimicrobial strategies such as antimicrobial peptides, bacteriophages, and agents that disrupt biofilms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriófagos / Infecção Hospitalar / Fibrose Cística Limite: Humans Idioma: En Revista: Arch Microbiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriófagos / Infecção Hospitalar / Fibrose Cística Limite: Humans Idioma: En Revista: Arch Microbiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Egito